Acorda Therapeutics (ACOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACOR | AMGN | BMY | VRTX | GILD |
| Company | Acorda Therapeutics | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.7800 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 0.8500 | 290.57 | 58.38 | 455.43 | 89.94 |
| Low | 0.6116 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 0.6610 | 289.62 | 58.17 | 450.61 | 89.49 |
| Change | -0.2187 | +1.75 | +0.29 | -0.62 | +0.86 |
| % Change | -24.86% | +0.61% | +0.50% | -0.14% | +0.97% |
| Volume | 416,900 | 1,450,462 | 3,314,577 | 655,638 | 1,630,362 |
| 20-Day Average Volume | 396,280 | 2,812,064 | 12,180,427 | 1,302,248 | 7,402,926 |
| Previous Close | 0.8797 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.1538 | 307.39 | 55.92 | 479.27 | 90.89 |
| 20-Day Raw Stochastic | 0.37% | 26.32% | 68.02% | 7.86% | 28.55% |
| 20-Day Relative Strength | 20.79% | 36.13% | 60.45% | 41.06% | 53.54% |
| Weighted Alpha | -37.54 | +1.69 | +25.71 | +18.29 | +26.03 |
| Today's Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 24% Sell | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -60.65% since 04/04/24 | -2.20% since 11/14/24 | -0.66% since 11/14/24 | -6.81% since 11/14/24 | -2.57% since 11/14/24 |
| Low | 0.6116 on 04/11/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 1.6214 on 04/05/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | -94.49% since 03/11/24 | -8.62% since 10/21/24 | +11.50% since 10/21/24 | -5.66% since 10/21/24 | +4.00% since 10/21/24 |
| Low | 0.6116 on 04/11/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 14.1100 on 03/15/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -95.96% since 01/11/24 | -12.07% since 08/21/24 | +19.97% since 08/21/24 | -7.22% since 08/21/24 | +19.45% since 08/21/24 |
| Low | 0.6116 on 04/11/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 18.0000 on 01/18/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -93.85% since 10/11/23 | -8.07% since 05/21/24 | +37.49% since 05/21/24 | +2.04% since 05/21/24 | +33.36% since 05/21/24 |
| Low | 0.6116 on 04/11/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 18.0000 on 01/18/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 821 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 1,242 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 117,630,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -252,850,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 37,990,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -217,760,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.40 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -175.32 on 04/01/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 05/09/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |